Persistence to antihypertensive drug treatment in Swedish primary healthcare

European Journal of Clinical Pharmacology

Volumn 69, Issue 11, 2013, Pages 1955-1964

  Qvarnström, Miriam ^a   Kahan, Thomas ^b   Kieler, Helle ^a   Brandt, Lena ^a   Hasselström, Jan ^c   Bengtsson Boström, Kristina ^d   Manhem, Karin ^e   Hjerpe, Per ^d   Wettermark, Björn ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d R and D Centre Skaraborg Primary Care   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blood pressure; Drug therapy; Hypertension; Persistence; Primary health care; Socioeconomy

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT IDENTIFICATION; PRESCRIPTION; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SEX DIFFERENCE; SWEDEN; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PRIMARY HEALTH CARE; SWEDEN;

EID: 84886776636     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-013-1555-z     Document Type: Article

References (49)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365(9455):217-223. doi: 10.1016/S0140-6736(05)17741-1
2. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, Buchbinder R, Bull F, Burnett RT, Byers TE, Calabria B, Carapetis J, Carnahan E, Chafe Z, Charlson F, Chen H, Chen JS, Cheng AT, Child JC, Cohen A, Colson KE, Cowie BC, Darby S, Darling S, Davis A, Degenhardt L, Dentener F, Des Jarlais DC, Devries K, Dherani M, Ding EL, Dorsey ER, Driscoll T, Edmond K, Ali SE, Engell RE, Erwin PJ, Fahimi S, Falder G, Farzadfar F, Ferrari A, Finucane MM, Flaxman S, Fowkes FG, Freedman G, Freeman MK, Gakidou E, Ghosh S, Giovannucci E, Gmel G, Graham K, Grainger R, Grant B, Gunnell D, Gutierrez HR, Hall W, Hoek HW, Hogan A, Hosgood HD 3rd, Hoy D, Hu H, Hubbell BJ, Hutchings SJ, Ibeanusi SE, Jacklyn GL, Jasrasaria R, Jonas JB, Kan H, Kanis JA, Kassebaum N, Kawakami N, Khang YH, Khatibzadeh S, Khoo JP, Kok C, Laden F, Lalloo R, Lan Q, Lathlean T, Leasher JL, Leigh J, Li Y, Lin JK, Lipshultz SE, London S, Lozano R, Lu Y, Mak J, Malekzadeh R, Mallinger L, Marcenes W, March L, Marks R, Martin R, McGale P, McGrath J, Mehta S, Mensah GA, Merriman TR, Micha R, Michaud C, Mishra V, Hanafiah KM, Mokdad AA, Morawska L, Mozaffarian D, Murphy T, Naghavi M, Neal B, Nelson PK, Nolla JM, Norman R, Olives C, Omer SB, Orchard J, Osborne R, Ostro B, Page A, Pandey KD, Parry CD, Passmore E, Patra J, Pearce N, Pelizzari PM, Petzold M, Phillips MR, Pope D, Pope CA 3rd, Powles J, Rao M, Razavi H, Rehfuess EA, Rehm JT, Ritz B, Rivara FP, Roberts T, Robinson C, Rodriguez-Portales JA, Romieu I, Room R, Rosenfeld LC, Roy A, Rushton L, Salomon JA, Sampson U, Sanchez-Riera L, Sanman E, Sapkota A, Seedat S, Shi P, Shield K, Shivakoti R, Singh GM, Sleet DA, Smith E, Smith KR, Stapelberg NJ, Steenland K, Stockl H, Stovner LJ, Straif K, Straney L, Thurston GD, Tran JH, Van Dingenen R, van Donkelaar A, Veerman JL, Vijayakumar L, Weintraub R, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams W, Wilson N, Woolf AD, Yip P, Zielinski JM, Lopez AD, Murray CJ, Ezzati M (2013) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2224-2260. doi: 10.1016/S0140-6736(12)61766-8
3. Staessen JA, Li Y, Thijs L, Wang JG (2005) Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials. Hypertens Res 28(5):385-407. doi: 10.1291/hypres.28.385
4. Law MR, Morris JK, Wald NJ (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338:b1665
5. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, Poulter N, Primatesta P, Stegmayr B, Thamm M (2004) Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 43(1):10-17. doi: 10.1161/01.HYP.0000103630.72812.10
6. Qvarnström M, Wettermark B, Ljungman C, Zarrinkoub R, Hasselström J, Manhem K, Sundström A, Kahan T (2011) Antihypertensive treatment and control in a large primary care population of 21 167 patients. J Hum Hypertens 25(8):484-491. doi: 10.1038/jhh.2010.86
7. Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F (2006) Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 12(3):239-245
8. Breekveldt-Postma NS, Penning-van Beest FJ, Siiskonen SJ, Koerselman J, Klungel OH, Falvey H, Vincze G, Herings RM (2008) Effect of persistent use of antihypertensives on blood pressure goal attainment. Curr Med Res Opin 24(4):1025-1031. doi: 10.1185/030079908X280554
9. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW (2002) Patient adherence and medical treatment outcomes: A meta-analysis. Med Care 40(9):794-811. doi: 10.1097/01.MLR.0000024612.61915.2D
10. Krousel-Wood M, Thomas S, Muntner P, Morisky D (2004) Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 19(4):357-362
11. Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK (2008) Medication compliance and persistence: terminology and definitions. Value Health 11(1):44-47. doi: 10.1111/j.1524-4733.2007.00213.x
12. Cramer JA, Benedict A, Muszbek N, Keskinaslan A, Khan ZM (2008) The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract 62(1):76-87. doi: 10.1111/j.1742-1241.2007.01630.x
13. Friedman O, McAlister FA, Yun L, Campbell NR, Tu K (2010) Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in ontario. Am J Med 123(2):173-181. doi: 10.1016/j.amjmed.2009. 08.008
14. Hasford J, Schroder-Bernhardi D, Rottenkolber M, Kostev K, Dietlein G (2007) Persistence with antihypertensive treatments: results of a 3-year follow-up cohort study. Eur J Clin Pharmacol 63(11):1055-1061. doi: 10.1007/s00228-007-0340-2
15. Nicotra F, Wettermark B, Sturkenboom MC, Parodi A, Bellocco R, Ekbom A, Merlino L, Leimanis A, Mancia G, Fored M, Corrao G (2009) Management of antihypertensive drugs in three European countries. J Hypertens 27(9):1917-1922. doi: 10.1097/HJH.0b013e32832d4692
16. Selmer R, Blix HS, Landmark K, Reikvam A (2012) Choice of initial antihypertensive drugs and persistence of drug use-a 4-year follow-up of 78,453 incident users. Eur J Clin Pharmacol 68(10):1435-1442. doi: 10.1007/s00228-012- 1261-2
17. Simons LA, Ortiz M, Calcino G (2008) Persistence with antihypertensive medication: Australia-wide experience, 2004-2006. Med J Aust 188(4):224-227
18. van Wijk BL, Shrank WH, Klungel OH, Schneeweiss S, Brookhart MA, Avorn J (2008) A cross-national study of the persistence of antihypertensive medication use in the elderly. J Hypertens 26(1):145-153. doi: 10.1097/HJH.0b013e32826308b4
19. Wong MC (2008) Short- and long-term discontinuation patterns of commonly prescribed antihypertensive drugs among a Chinese population: cohort study. J Hum Hypertens 22(6):435-437. doi: 10.1038/jhh.2008.13
20. Andrade SE, Kahler KH, Frech F, Chan KA (2006) Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 15(8):565-574. doi: 10.1002/pds.1230, discussion 575-567
21. Bautista LE (2008) Predictors of persistence with antihypertensive therapy: results from the NHANES. Am J Hypertens 21(2):183-188. doi: 10.1038/ajh.2007.33
22. Tamblyn R, Abrahamowicz M, Dauphinee D, Wenghofer E, Jacques A, Klass D, Smee S, Eguale T, Winslade N, Girard N, Bartman I, Buckeridge DL, Hanley JA (2010) Influence of physicians' management and communication ability on patients' persistence with antihypertensive medication. Arch Intern Med 170(12):1064-1072. doi: 10.1001/archinternmed.2010.167
23. Hasselström J, Zarrinkoub R, Holmquist C, Hjerpe P, Ljungman C, Qvarnström M, Wettermark B, Manhem K, Kahan T, Bengtsson Boström K (2013) The Swedish Primary Care Cardiovascular Database (SPCCD): 74 751 hypertensive primary care patients. Blood Pressure. In press
24. Kristianson KJ, Ljunggren H, Gustafsson LL (2009) Data extraction from a semi-structured electronic medical record system for outpatients: a model to facilitate the access and use of data for quality control and research. Health Informatics J 15(4):305-319. doi: 10.1177/1460458209345889
25. Hjerpe P, Merlo J, Ohlsson H, Bengtsson Boström K, Lindblad U (2010) Validity of registration of ICD codes and prescriptions in a research database in Swedish primary care: a cross-sectional study in Skaraborg primary care database. BMC Med Inform Decis Mak 10:23. doi: 10.1186/1472-6947-10-23
26. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A (2009) The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 24(11):659-667. doi: 10.1007/s10654-009-9350-y
27. Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundström A, Westerholm B, Rosén M (2007) The new Swedish Prescribed Drug Register-opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16(7):726-735. doi: 10.1002/pds.1294
28. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO (2011) External review and validation of the Swedish national inpatient register. BMC Publ Health 11:450. doi: 10.1186/1471-2458-11- 450
29. Johansson LA, Westerling R (2000) Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics. Int J Epidemiol 29(3):495-502
30. Caetano PA, Lam JM, Morgan SG (2006) Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilization. Clin Ther 28(9):1411-1424. doi: 10.1016/j.clinthera.2006.09.021, discussion 1410
31. Saleh SS, Szebenyi S, Carter JA, Zacher C, Belletti D (2008) Patterns and associated health services costs of antihypertensive drug modifications. J Clin Hypertens (Greenwich) 10(1):43-50
32. Erkens JA, Panneman MM, Klungel OH, van den Boom G, Prescott MF, Herings RM (2005) Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study. Pharmacoepidemiol Drug Saf 14(11):795-803. doi: 10.1002/pds.1156
33. Sagie A, Larson MG, Levy D (1993) The natural history of borderline isolated systolic hypertension. N Engl J Med 329(26):1912-1917. doi: 10.1056/NEJM199312233292602
34. Soldin OP, Mattison DR (2009) Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 48(3):143-157. doi: 10.2165/00003088- 200948030-00001
35. Vinker S, Alkalay A, Hoffman RD, Elhayany A, Kaiserman I, Kitai E (2008) Long-term adherence to antihypertensive therapy: a survey in four primary care clinics. Expert Opin Pharmacother 9(8):1271-1277. doi: 10.1517/14656566.9.8.1271
36. Hoer A, Gothe H, Khan ZM, Schiffhorst G, Vincze G, Haussler B (2007) Persistence and adherence with antihypertensive drug therapy in a German sickness fund population. J Hum Hypertens 21(9):744-746. doi: 10.1038/sj.jhh.1002223
37. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R (9349) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903-1913
38. Briesacher BA, Limcangco MR, Frech-Tamas F (2007) New-user persistence with antihypertensives and prescription drug cost-sharing. J Clin Hypertens (Greenwich) 9(11):831-836
39. Wettermark B, Godman B, Neovius M, Hedberg N, Mellgren TO, Kahan T (2010) Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment. Health Policy 94(3):221-229. doi: 10.1016/j.healthpol.2009.09.014
40. Krueger KP, Berger BA, Felkey B (2005) Medication adherence and persistence: a comprehensive review. Adv Ther 22(4):313-356
41. Helman CG (2000) Culture, health and illness. Butterworth Heineman, Oxford
42. Carlsson AC, Wändell PE, de Faire U, Hellenius ML (2008) Prevalence of hypertension in immigrants and Swedish-born individuals, a cross-sectional study of 60-year-old men and women in Sweden. J Hypertens 26(12):2295-2302. doi: 10.1097/HJH.0b013e32831391c3
43. Melloni C, Alexander KP, Ou FS, LaPointe NM, Roe MT, Newby LK, Baloch K, Ho PM, Rumsfeld JS, Peterson ED (2009) Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome. Am J Cardiol 104(2):175-181. doi: 10.1016/j.amjcard.2009.03.013
44. Ekedahl A, Månsson N (2004) Unclaimed prescriptions after automated prescription transmittals to pharmacies. Pharm World Sci 26(1):26-31
45. Ax F, Ekedahl A (2010) Electronically transmitted prescriptions not picked up at pharmacies in Sweden. Res Social Adm Pharm 6(1):70-77. doi: 10.1016/j.sapharm.2009.06.003
46. Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, Weissman JS (2010) Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med 25(4):284-290. doi: 10.1007/s11606-010-1253-9
47. Fischer MA, Choudhry NK, Brill G, Avorn J, Schneeweiss S, Hutchins D, Liberman JN, Brennan TA, Shrank WH (2011) Trouble getting started: predictors of primary medication nonadherence. Am J Med 124(11):1081. doi: 10.1016/j.amjmed.2011.05.028, e1089-1022
48. Sörensen HT, Sabroe S, Olsen J (1996) A framework for evaluation of secondary data sources for epidemiological research. Int J Epidemiol 25(2):435-442
49. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A (2006) Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculation. J Clin Epidemiol 59(1):11-17. doi: 10.1016/j.jclinepi. 2005.05.005